» Articles » PMID: 29875138

COPD Stands for Complex Obstructive Pulmonary Disease

Overview
Journal Eur Respir Rev
Specialty Pulmonary Medicine
Date 2018 Jun 8
PMID 29875138
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Chronic obstructive pulmonary disease (COPD) has extensively been reported as a complex disease affecting patients' health beyond the lungs with a variety of intra- and extrapulmonary components and considerable variability between individuals. This review discusses the assessment of this complexity and underlines the importance of transdisciplinary management programmes addressing the physical, emotional and social health of the individual patient.COPD management is challenging and requires advanced, sophisticated strategies meeting the patient's individual needs. Due to the heterogeneity and complexity of the disease leading to non-linear and consequently poorly predictable treatment responses, multidimensional patient profiling is crucial to identify the right COPD patient for the right treatment. Current methods are often restricted to general, well-known and commonly used assessments neglecting potentially relevant (interactions between) individual, unique "traits" to finally ensure personalised treatment. Dynamic, personalised and holistic approaches are needed to tackle this multifaceted disease and to ensure personalised medicine and value-based healthcare.

Citing Articles

The Role of Diaphragmatic Ultrasound in Identifying Sarcopenia in COPD Patients: A Cross-Sectional Study.

Yetkin N, Akin S, Kocaslan D, Baran B, Rabahoglu B, Oymak F Int J Chron Obstruct Pulmon Dis. 2025; 20():1-9.

PMID: 39777216 PMC: 11701918. DOI: 10.2147/COPD.S492191.


Lipolysis engages CD36 to promote ZBP1-mediated necroptosis-impairing lung regeneration in COPD.

Wang J, Wang R, Li Y, Huang J, Liu Y, Wang J Cell Rep Med. 2024; 5(9):101732.

PMID: 39255796 PMC: 11525022. DOI: 10.1016/j.xcrm.2024.101732.


Symptom burden and its associations with clinical characteristics in patients with COPD: a clustering approach.

Houben-Wilke S, Deng Q, Janssen D, Franssen F, Spruit M ERJ Open Res. 2024; 10(4).

PMID: 39104954 PMC: 11299006. DOI: 10.1183/23120541.01052-2023.


Cellular and Molecular Biology of Mitochondria in Chronic Obstructive Pulmonary Disease.

Li C, Liu S Int J Mol Sci. 2024; 25(14).

PMID: 39063022 PMC: 11276859. DOI: 10.3390/ijms25147780.


Association of dietary inflammatory indices with sarcopenia and all-cause mortality in COPD patients.

Jiang Q, Ma Z, Sun J, Li Y Front Nutr. 2024; 11:1395170.

PMID: 38846543 PMC: 11153795. DOI: 10.3389/fnut.2024.1395170.


References
1.
Wouters E, Augustin I . Process of pulmonary rehabilitation and program organization. Eur J Phys Rehabil Med. 2011; 47(3):475-82. View

2.
Agusti A . The path to personalised medicine in COPD. Thorax. 2014; 69(9):857-64. DOI: 10.1136/thoraxjnl-2014-205507. View

3.
Hodgkin J, Farrell M, Gibson S, Kanner R, KASS I, Lampton L . American Thoracic Society. Medical Section of the American Lung Association. Pulmonary rehabilitation. Am Rev Respir Dis. 1981; 124(5):663-6. View

4.
Agusti A, Gea J, Faner R . Biomarkers, the control panel and personalized COPD medicine. Respirology. 2015; 21(1):24-33. DOI: 10.1111/resp.12585. View

5.
Pinto L, Alghamdi M, Benedetti A, Zaihra T, Landry T, Bourbeau J . Derivation and validation of clinical phenotypes for COPD: a systematic review. Respir Res. 2015; 16:50. PMC: 4460884. DOI: 10.1186/s12931-015-0208-4. View